Global Liquid Biopsy Products Market to Reach $12.9 Billion by 2031 | CAGR 25.5%
Global Liquid Biopsy Products Market The global Liquid Biopsy Products market was valued at USD 2,690 million in 2024 and is projected to reach approximately USD 12,920 million by 2031 , expanding at a compound annual growth rate (CAGR) of 25.5% during the forecast period from 2025 to 2031. Liquid biopsy technologies are emerging as a non-invasive alternative to traditional tissue biopsies for cancer detection, diagnosis, and monitoring, driven by growing demand for personalized medicine and early cancer detection. Get Free Sample Report: https://www.qyresearch.in/request-sample/pharma-healthcare-global-liquid-biopsy-products-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031?utm_source=linkedin&utm_campaign=ruchika Key Trends Include: Rising adoption of next-generation sequencing (NGS) in liquid biopsy platforms. Development of multi-cancer early detection (MCED) tests. ...